TipRanks
Go Ultimate75% OFF

Art's-Way Manufacturing Co (ID2) AI Stock Analysis

0 Followers
DE:ID2

Art's-Way Manufacturing Co

(Frankfurt:ID2)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Modular Buildings BacklogThe sharp backlog expansion improves forward demand visibility for the Modular Buildings segment and supports a larger manufacturing workload over the next several quarters. Although delivery depends on customer schedules and execution, the contracts represent meaningful committed activity and customer confidence.
Negative Factors
Profitability PressureThe return to a net loss and very modest EBITDA margin indicates limited earnings resilience in the current operating profile. Thin profitability leaves less room to absorb cost increases or demand weakness and makes sustained shareholder returns harder to achieve without stronger margins.

Art's-Way Manufacturing Co (ID2) vs. iShares MSCI Germany ETF (EWG)

-20%0%20%40%60%80%DE:ID2+24.61%EWG+3.55%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
EUR 14.21M
Dividend Yield
―
Average Volume (3M)
35
Price to Earnings (P/E)
-30.8
Beta (1Y)
0.26
Revenue Growth
-1.05%
EPS Growth
-121.95%
Country
Germany
Employees
97
Sector
Industrials
Sector Strength
63
Industry
Agricultural - Machinery

Art's-Way Manufacturing Co Business Overview & Revenue Model

Company Description

Art's-Way Manufacturing Co., Inc. manufactures and sells agricultural equipment, and specialized modular science and agricultural buildings in the United States and internationally. It operates through two segments, Agricultural Products and Modular...

Art's-Way Manufacturing Co Risk Analysis

Art's-Way Manufacturing Co disclosed 2 risk factors in its most recent earnings report. Art's-Way Manufacturing Co reported the most risks in the "Legal & Regulatory" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Legal & Regulatory - Litigation, compliance, new legislation, and taxation risks

Latest Risks Added

1 New Risk
1..As a smaller reporting company, we are not required to provide disclosure pursuant to this Item.Q3, 2026

Art's-Way Manufacturing Co Peers Comparison

Overall Rating

UnderperformOutperform
Sector (63)

Financial Indicators

DE:ID2 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
GENCGENC82Outperform$249.18M16.836.82%―-6.39%-1.99%
Sector *63Neutral$10.79B15.437.44%2.01%2.89%-14.66%
RYMRYM48Neutral$34.53M-2.6521.31%―706.93%71.95%
HYFMHYFM41Neutral$3.93M-0.012175.86%―-34.07%-352.84%
XOSXOS40Underperform$34.55M-1.50-80.31%―-26.88%72.36%

* Industrials Sector Average

Performance Comparison

0%100%200%DE:ID2GENCHYFMXOSRYMDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
DE:ID2 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
DE:ID2Art's-way Manufacturing2.380.4422.68%
GENCGencor Industries, Inc.17.003.1322.57%
HYFMHydrofarm Holdings Group Inc0.82-1.42-63.57%
XOSXos, Inc.2.430.010.41%
RYMRythm, Inc.15.84-15.16-48.90%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.